All Cancer articles – Page 3
-
HSJ InteractiveHow might pathways evolve to free up capacity in cancer care?
An HSJ roundtable, fully funded and initiated by AbbVie, considered which pathway changes might support best use of capacity
-
NewsExclusive: NHSE targeting 50% cut to waiting list
NHS England is floating proposals to cut the elective waiting list by nearly 50 per cent to under 4 million over the next five years, HSJ can reveal.
-
HSJ PartnersBetter, faster, stronger: Incentivising capacity for NHS cancer care
By prioritising a new approach to incentives, policymakers can help create system capacity in cancer services, especially at a time when organisational reform and major financial investment are unlikely, writes David Brocklehurst
-
HSJ LocalTrust ‘fighting losing battle’ over elective waits, CEO admits
A hospital chief executive has blamed a “mind-blowing increase” in cancer referrals for his trust’s deterioration in performance on long elective waits.
-
NewsContamination risk may cost trust £50m a year
A trust could face a £50m yearly bill for outsourcing preparation of chemotherapy drugs, after external inspections raised concern about a leaking roof and other infection risks.
-
NewsNHSE looks to match Scotland on cancer tests
NHS England is piloting a scheme to lower the threshold for getting a bowel cancer scan after screening, which would bring it in line with standards in Scotland.
-
Expert BriefingNorth by North West: Skin in the game
Essential insight into NHS matters in the North West of England. Contact me in confidence here.
-
NewsDecade long battle ends with decision on cancer services
Children’s cancer services in London and the south east will be hosted by Guy’s and St Thomas’ Foundation Trust, NHS England has announced, following more than a decade of safety concerns surrounding the current model.
-
HSJ PartnersTackling the systemic anti-cancer treatment capacity crisis collaboratively
Co-authors Stephanie Harvey and Sacha Howell shed light on how redesigning breast cancer care pathways for accessible and efficient treatment delivery can improve patient outcomes amidst the face of NHS capacity challenges
-
NewsNHS backlogs drive £20m boost for private cancer firm
A private cancer provider has grown its turnover by £20m – more than 20 per cent – in the past year on the back of the NHS cancer backlog, it reports.
-
NewsTop trust warns GPs of 15-week wait for scans
England’s largest hospital trust has written to GPs warning their patients face 15-week waits for routine MRIs, ultrasound and CT scans.
-
Expert BriefingThe Integrator: What the DHSC restructure means
Insider tales and must-read analysis on how integration is reshaping health and care systems, NHS providers, primary care, and commissioning. This week by deputy editor Dave West.
-
HSJ InteractiveHow to cut time out of cancer pathways
An HSJ webinar explored the role of digital workers in releasing capacity and reducing waiting times in cancer pathways
-
HSJ InteractiveHow can ICSs navigate the EPR landscape for improved information flow, and what part does convergence play in this?
The panel at a recent HSJ webinar discussed the convergence agenda; how it can be achieved, what the benefits and challenges of implementation are, and the role it plays in improving patient care
-
Expert BriefingThe Integrator: New model neighbourhood
Insider tales and must-read analysis on how integration is reshaping health and care systems, NHS providers, primary care, and commissioning. This week by deputy editor Dave West.
-
CommentThe rationing of cancer care must be addressed
Amid positive strides in addressing oncology capacity challenges, the new health secretary must now commit to sustained action, clear funding, and strategic technology integration for lasting improvements in cancer care, writes Tom Roques
-
HSJ InteractiveHSJ webinar discussed how to cut time out of cancer pathways
In association with An on-demand version of this webinar is available. Meeting cancer performance targets is a challenge for many trusts with waiting times for a diagnosis and treatment growing since the pandemic. But this is a worrying time for patients as well and they would ...
-
HSJ PartnersHow can a joined-up ILD pathway improve patient outcomes?
This article – the second in a four-part series looking at services for patients with Interstitial Lung Disease (ILD) – looks in particular at the pathway, and how a more optimal pathway could improve service delivery. The article has been initiated, funded, and written by Boehringer Ingelheim.
-
NewsCancer, prevention and learning disabilities set for ‘sensible’ budget raids
Local leaders will be permitted to cut spending on the development of cancer, prevention, learning disabilities and autism services, as they bid to deliver their financial plans this year, HSJ understands.
-
HSJ PartnersHow to improve ILD services with better data collection
This article – the first in a four-part series looking at services for patients with Interstitial Lung Disease (ILD) – looks in particular at data collection, and how better data collection could improve service delivery. The article has been initiated and funded by Boehringer Ingelheim. It was drafted by MHP ...